The complex integration of carcinogenic mechanisms in NAFLD such as chronic inflammation, lipotoxicity, and high insulin levels can lead to a higher HCC risk, especially among patients with underlying T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.